My husband has the kras mutation for lung cancer. is there immunotherapy that is effective?

Maybe: Kras mutation has predicted for lesser benefits from chemo and egfr inhibitors. There have been trials looking @ selumetinib, bortezomib, and other as yet unnamed drugs in phase i & ii studies. Consider please: http://clinicaltrials.Gov.

I'm sorry: I'm sorry about your husband. Kras is an indicator that the super-pricey "magic bullet" medications that arrest some lung cancers for a few months won't help. But truth be told, i'd rather kras and a loving wife than a more favorable short-term outlook and be alone. I will be thinking of you both in the weeks ahead.

See below: Unfortunately, development of drugs targeting kras mutation have been a disappointment. Having said that, it is possible to enroll in immunotherapy clinical trials with drugs targeting the pd1/pdl1 pathway. These drugs seem promising and offer durable responses in some patients with nsclc; (in tumors expressing pdl1).